Using a Clinicopathologic and Gene Expression (CP-GEP) Model to Identify Stage I-II Melanoma Patients at Risk of Disease Relapse.
Mulder EEAP, Johansson I, Grünhagen DJ, Tempel D, Rentroia-Pacheco B, Dwarkasing JT, Verver D, Mooyaart AL, van der Veldt AAM, Wakkee M, Nijsten TEC, Verhoef C, Mattsson J, Ny L, Hollestein LM, Olofsson Bagge R.
Mulder EEAP, et al. Among authors: grunhagen dj.
Cancers (Basel). 2022 Jun 9;14(12):2854. doi: 10.3390/cancers14122854.
Cancers (Basel). 2022.
PMID: 35740520
Free PMC article.